Biparametric MRI Screening for High-Risk Prostate Cancer
This study is looking at whether a special type of MRI, called biparametric MRI (bpMRI), can improve prostate cancer screening for men at high risk. You might be eligible if you are a man between 40 and 55 years old, have a PSA (prostate-specific antigen) level between 1.0 and 2.5 ng/dL, and have a higher risk of prostate cancer (for example, if you are Black, have a close relative with prostate cancer, or have certain genetic changes like BRCA). The study aims to see if bpMRI, along with PSA testing, can help find prostate cancer earlier in this group. The study is currently unclear on its recruitment status.
- Study design
- This is an interventional study planning to enroll 100 men. It will use biparametric MRI as a diagnostic test.
- What's involved
- If you have a suspicious bpMRI, you may be recommended for an MRI/US fusion biopsy. All participants will be followed for 5 years.
- Compensation
- Not stated in the trial record.
- Follow-up
- All subjects will be followed for 5 years after the initial tests.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Ardeshir Rastinehad, DO · PRINCIPAL_INVESTIGATOR · Northwell Health
- Manish Vira, MD · PRINCIPAL_INVESTIGATOR · Northwell Health
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Proportion of suspicious lesions on MRI in men with PSA less than 2.5 ng/ml3 months
To determine the incidence of positive mpMRI prostate in a high-risk cohort of men as a screening tool for prostate cancer.